Increased erythrocyte mean corpuscular volume by methotrexate predicts clinical response in psoriatic arthritis

Rheumatology (Oxford). 2022 Aug 30;61(9):e270-e273. doi: 10.1093/rheumatology/keac276.

Authors

Muhammad R A Shipa¹, Lawrence Langley², Benjamin Sacks², Su-Ann Yeoh¹, M D Mainuddin³, Dev Mukerjee³, Madhura Castelino¹, Michael R Ehrenstein¹

Affiliations

¹ Department of Rheumatology, University College London.
² Department of Rheumatology, University College London Hospitals NHS Foundation Trust.
³ Department of Rheumatology, North Middlesex University Hospital NHS Trust, London, UK.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Letter

MeSH terms

Antirheumatic Agents* / therapeutic use
Arthritis, Psoriatic* / drug therapy
Erythrocyte Indices
Erythrocytes
Humans
Methotrexate / therapeutic use

Substances

Antirheumatic Agents
Methotrexate

Grants and funding

20873/VAC_/Versus Arthritis/United Kingdom